Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Subgroup analysis in MS trials.
Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells.
A Model of Population and Subject (MOPS) Intensities with Application to Multiple Sclerosis Lesion Segmentation.
Immunological follow-up of patients with neuromyelitis optica: Is there a good biomarker?
Beta2-adrenergic agonist use and the risk of multiple sclerosis: a total population-based case-control study.
Vitamin D receptor Bsm1 polymorphism, calcium metabolism and bone mineral density in patients with multiple sclerosis: a pilot study.
Autoimmune Aquaporin-4 Myopathy in Neuromyelitis Optica Spectrum.
Comparison between Trans-Cranial Electromagnetic Stimulation and Low-Level Laser on Modulation of Trigeminal Neuralgia.
Concurrent acute disseminated encephalomyelitis and Guillain-Barré syndrome in a child.
Murine K2P5.1 Deficiency Has No Impact on Autoimmune Neuroinflammation due to Compensatory K2P3.1- and KV1.3-Dependent Mechanisms.
A Friend in Need may not be a Friend Indeed: Role of Microglia in Neurodegenerative Diseases.
Prorating WAIS-IV Summary Scores for Patients with Relapsing-Remitting Multiple Sclerosis.
The Encephalitogenic, Human Myelin Oligodendrocyte Glycoprotein-Induced Antibody Repertoire Is Directed towards Multiple Epitopes in C57BL/6-Immunized Mice.
A Case Report of Obsessive-Compulsive Disorder Following Acute Disseminated Encephalomyelitis.
Madariaga Virus Infection Associated with a Case of Acute Disseminated Encephalomyelitis.
[Intrathecal immunoglobulin production in the diagnosis and differential diagnosis of multiple sclerosis.]
Cognitive impairment in a population-based study of patients with multiple sclerosis: differences between late relapsing-remitting, secondary progressive and primary progressive multiple sclerosis.
Voltage-gated potassium channel antibodies: Game over.
Nutraceuticals against Neurodegeneration: A Mechanistic Insight.
Can the Fatigue Severity Scale 7-item version be used across different patient populations as a generic fatigue measure - a comparative study using a Rasch model approach.
A novel model of demyelination and remyelination in a GFP-transgenic zebrafish.
Melatonin Redox Activity. Its Potential Clinical Application in Neurodegenerative Disorders.
Semaphorins 3A and 7A: potential immune and neuroregenerative targets in multiple sclerosis.
Transglutaminase 2 exacerbates experimental autoimmune encephalomyelitis through positive regulation of encephalitogenic T cell differentiation and inflammation.
The expanded spectrum of neuromyelitis optica: evidences for a new definition.
Pages
« first
‹ previous
…
378
379
380
381
382
383
384
385
386
…
next ›
last »